NPM1 and acute myeloid leukemia: Relevant to this, nucleophosmin (NPM1) gene mutations, observed in nearly 30% of adult AML patients, accounting for approximately 50–60% of cases among the cytogenetically normal AML subgroup, represent one of the most frequent genetic lesions documented in AML [5,6,7,8].